Twist Bioscience Corporation
TWST NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 3, 2026
ET
EPS Est.
-0.51
EPS Actual
-0.56
Revenue Est.
$114.5M
Revenue Actual
$118.4M
Next Earnings Report
Date
Nov 13, 2026 · Fri
Time
Pre-market
Fiscal Period
FY2026 Q4
EPS Est.
-0.44
Revenue Est.
$123.5M
Company Overview
Twist Bioscience Corporation (ticker TWST) is listed on NASDAQ with a market cap of about $9.07B. Its next earnings report (FY2026 Q4) is expected on Nov 13, 2026 (ET), Pre-market, with consensus EPS of -0.44. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Feb 3, 2023 → Aug 3, 2026
Feb 3, 2023Range: -1.47 ~ -0.45Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | -0.51 | -0.56 | $114.5M | $118.4M |
| May 4, 2026 | -- | -0.49 | Below forecast↓-0.71 | $107.6M | $110.7M |
| Feb 2, 2026 | -- | -0.48 | -0.50 | $101.9M | $103.7M |
| Nov 14, 2025 | -- | -0.50 | -0.45 | $97.4M | $99M |
| Aug 4, 2025 | -- | -0.54 | -0.47 | $97.4M | $96.1M |
| May 5, 2025 | -- | -0.56 | Below forecast↓-0.66 | $95.4M | $92.8M |
| Feb 3, 2025 | -- | -0.62 | -0.53 | $86.9M | $88.7M |
| Nov 18, 2024 | -- | -0.71 | Above forecast↑-0.59 | $82.7M | $84.7M |
| Aug 2, 2024 | -- | -0.79 | Below forecast↓-1.47 | $77.4M | $81.5M |
| May 2, 2024 | -- | -0.84 | -0.79 | $77.4M | $75.3M |
| Feb 2, 2024 | -- | -0.80 | -0.75 | $67.6M | $71.5M |
| Nov 17, 2023 | -- | -0.94 | -0.81 | $63.4M | $66.9M |
| Aug 4, 2023 | -- | -1.14 | -1.01 | $60.5M | $63.7M |
| May 5, 2023 | -- | -1.09 | -1.06 | $56.7M | $60.2M |
| Feb 3, 2023 | -- | -1.09 | Above forecast↑-0.74 | $54.4M | $54.2M |
Original Filings (SEC)
8-K2026-08-19 ↗
8-K2026-08-19 ↗
8-K2026-08-05 ↗
10-Q2026-08-03 ↗
8-K2026-08-03 ↗
10-Q2026-05-04 ↗
8-K2026-05-04 ↗
8-K2026-02-17 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
